Cargando…

A 41-year-old man with polyarthritis and severe autonomic neuropathy

Orthostasis due to autonomic neuropathy can cause severe debilitation and prove refractory to treatment. This report describes a case of severe sympathetic and parasympathetic autonomic dysfunction as a consequence of acetylcholine receptor antibodies and Sjogren’s syndrome. Symptomatic management,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourcier, Matthew E, Vinik, Aaron I
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621382/
https://www.ncbi.nlm.nih.gov/pubmed/19209266
_version_ 1782163403261870080
author Bourcier, Matthew E
Vinik, Aaron I
author_facet Bourcier, Matthew E
Vinik, Aaron I
author_sort Bourcier, Matthew E
collection PubMed
description Orthostasis due to autonomic neuropathy can cause severe debilitation and prove refractory to treatment. This report describes a case of severe sympathetic and parasympathetic autonomic dysfunction as a consequence of acetylcholine receptor antibodies and Sjogren’s syndrome. Symptomatic management, plasma fluid expanders, and IVIG therapy failed to offer a salutary response to the condition. Etanercept therapy provided improvement of the orthostasis and autonomic function measured as high and low frequency respiratory effects on heart rate variability as well as enhancement of skin blood flow using Laser Doppler. It would be of considerable interest to determine the effectiveness of etanercept in other autoimmune neuropathies.
format Text
id pubmed-2621382
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26213822009-02-10 A 41-year-old man with polyarthritis and severe autonomic neuropathy Bourcier, Matthew E Vinik, Aaron I Ther Clin Risk Manag Case Report Orthostasis due to autonomic neuropathy can cause severe debilitation and prove refractory to treatment. This report describes a case of severe sympathetic and parasympathetic autonomic dysfunction as a consequence of acetylcholine receptor antibodies and Sjogren’s syndrome. Symptomatic management, plasma fluid expanders, and IVIG therapy failed to offer a salutary response to the condition. Etanercept therapy provided improvement of the orthostasis and autonomic function measured as high and low frequency respiratory effects on heart rate variability as well as enhancement of skin blood flow using Laser Doppler. It would be of considerable interest to determine the effectiveness of etanercept in other autoimmune neuropathies. Dove Medical Press 2008-08 2008-08 /pmc/articles/PMC2621382/ /pubmed/19209266 Text en © 2008 Dove Medical Press Limited. All rights reserved
spellingShingle Case Report
Bourcier, Matthew E
Vinik, Aaron I
A 41-year-old man with polyarthritis and severe autonomic neuropathy
title A 41-year-old man with polyarthritis and severe autonomic neuropathy
title_full A 41-year-old man with polyarthritis and severe autonomic neuropathy
title_fullStr A 41-year-old man with polyarthritis and severe autonomic neuropathy
title_full_unstemmed A 41-year-old man with polyarthritis and severe autonomic neuropathy
title_short A 41-year-old man with polyarthritis and severe autonomic neuropathy
title_sort 41-year-old man with polyarthritis and severe autonomic neuropathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621382/
https://www.ncbi.nlm.nih.gov/pubmed/19209266
work_keys_str_mv AT bourciermatthewe a41yearoldmanwithpolyarthritisandsevereautonomicneuropathy
AT vinikaaroni a41yearoldmanwithpolyarthritisandsevereautonomicneuropathy
AT bourciermatthewe 41yearoldmanwithpolyarthritisandsevereautonomicneuropathy
AT vinikaaroni 41yearoldmanwithpolyarthritisandsevereautonomicneuropathy